Moderna Inc plans the price of the vaccine it develops against coronavirus to be $ 50 to $ 60, a figure higher than what other vaccine manufacturers have agreed to charge governments, Financial Times reported Tuesday, July 28, 2020, citing sources. with knowledge of the subject.
The price would apply to the United States and other high-income countries, according to the report.
Moderna’s proposed price of $ 50 to $ 60 per treatment, or $ 25 to $ 30 per dose, is higher than that disclosed by Pfizer Inc and its German partner BioNTech in an agreement with the United States government, which is $ 39 per treatment or $ 19.50 per dose. Pfizer, Moderna and Merck & Co have said they plan to make a profit from their vaccines, while some drug makers, including Johnson & Johnson, have announced that their vaccines will be non-profit.
Pfizer and BioNTech, for their part, confirmed that they would charge the United States Government a value of $ 19.50 per dose.
The first company to talk about possible costs was the one made by the University of Oxford. Recently, the CEO of the pharmaceutical company AstraZeneca, Pacal Soriot, announced that each of his doses would be priced at between $ 3 and $ 4. Soriot stated: “Our goal is to supply the vaccine to everyone. We will deliver the vaccine at cost price worldwide. ”
Stephen Hoge, president of Moderna, differentiated himself from the other laboratories and stated that they will not sell their vaccine “at cost”. In this way, many countries could choose other pharmaceutical companies.